Addus HomeCare Form 4 shows new equity grant to Director Jean Rush

Rhea-AI Filing Summary

Form 4 filing – Addus HomeCare Corp. (ADUS)

Non-employee director Jean Rush reported the grant of 1,172 shares of restricted common stock on 06/18/2025. The award was received at $0 cost and is scheduled to vest in full on 06/18/2026. Following the transaction, Rush’s direct beneficial ownership stands at 9,221 shares. No derivative securities were created or disposed of, and there were no share sales.

The transaction appears to be a routine component of director equity compensation designed to align board and shareholder interests. The filing, signed by attorney-in-fact Brian Poff on 06/20/2025, does not reference a Rule 10b5-1 trading plan.

Insights

Corporate Governance Expert

TL;DR: Standard director RSU grant; neutral governance signal and immaterial to overall float.

The 1,172-share restricted stock grant to Jean Rush reflects customary non-employee director compensation. Such equity awards strengthen alignment with shareholder value creation but are not quantitatively material given the small size and lack of cash outflow. No red flags emerge regarding control, insider selling, or derivative exposure. I view the disclosure as routine, with neutral governance impact.

Portfolio Manager

TL;DR: Minor ownership increase; no trading signal for ADUS shares.

The award lifts the director’s stake to 9,221 shares, a modest holding that does not meaningfully alter insider ownership dynamics. Absence of sales or derivatives suggests no negative outlook by the insider. From a portfolio-allocation perspective, the event is non-impactful to valuation or liquidity and therefore does not warrant a position change.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

RUSH JEAN

(Last) (First) (Middle)

6303 COWBOYS WAY

SUITE 600

(Street)

FRISCO TX 75034

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Addus HomeCare Corp [ ADUS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/18/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/18/2025		A		1,172(1)	A	$0	9,221	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Restricted shares granted to non-employee directors that will vest in full on June 18, 2026.

	/s/ Brian Poff, Attorney-In-Fact for Jean Rush	06/20/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many shares did Jean Rush receive according to the ADUS Form 4?

1,172 restricted shares were granted on 06/18/2025.

When will the restricted shares granted to the ADUS director vest?

They vest in full on 06/18/2026.

What is Jean Rush’s total direct ownership in ADUS after the transaction?

Her direct beneficial ownership is 9,221 common shares.

Did the ADUS Form 4 report any share sales or derivative transactions?

No sales or derivative securities were reported; only an equity grant was disclosed.

Was a Rule 10b5-1 trading plan mentioned in the filing?

The filing did not indicate that the transaction was made under a Rule 10b5-1 plan.